GW Pharmaceuticals PLC GWPH:NASDAQ

Last Price$154.19NASDAQ Previous Close - Last Trade as of 3:59PM ET 8/16/19

Today's Change+1.27(0.83%)
Bid (Size)$152.50 (5)
Ask (Size)$162.00 (4)
Day Low / High$152.94 - 155.99
Volume275.8 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 08/16/2019

 

GW Pharmaceuticals PLC ( NASDAQ )

Price: $154.19
Change: +1.27 (0.83%)
Volume: 275.8 K
3:59PM ET 8/16/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

ADR Top % Movers in Pre-Market Trading
6:34AM ET 8/15/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers RIO +0.7% TEVA +0.6% SAN +0.5% GSK +0.1% Losers NOK -1.8% BBL -0.7% BP -0.6% GWPH -0.4% BBVA -0.2% HSBC...

European ADRs Move Lower in Friday Trading
10:48AM ET 8/09/2019 MT Newswires

American depositary receipts of European stocks were trading 1.19% lower at 989.06 on the BNY Mellon Europe Select ADR Index on Friday. In continental...

ADR Top % Movers in Pre-Market Trading
6:27AM ET 8/09/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers SAN +0.3% Losers RIO -1.5% VOD -1.4% HSBC -1.1% CS -1.0% TEVA -1.0% BP -1.0% BBL -0.9% NOK -0.8% GWPH...

European ADRs Move Higher in Thursday Trading
10:31AM ET 8/08/2019 MT Newswires

American depositary receipts of European stocks were trading 0.18% higher at 994.41 on the BNY Mellon Europe Select ADR Index on Thursday. In continental...

View all Commentary and Analysis

Pricing Amyris Into 2020
3:58PM ET 8/08/2019 Seeking Alpha

Making The Case For An Actively Managed Cannabis ETF Portfolio With Dan Ahrens (Podcast)
7:15AM ET 8/07/2019 Seeking Alpha

GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q2 2019 Results - Earnings Call Transcript
9:26PM ET 8/06/2019 Seeking Alpha

AMD Portfolio: Final Performance
1:41PM ET 7/31/2019 Seeking Alpha

Company Profile

Business DescriptionGW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. View company web site for more details
AddressSovereign House
Cambridge, Cambridgeshire CB24 9BZ
Phone+44.1223.266800
Number of Employees801
Recent SEC Filing08/14/20194
Chief Executive Officer & Executive DirectorJustin D. Gover
Chief Operating OfficerChristopher John Tovey
CFO & Principal Accounting OfficerScott M. Giacobello
Chief Medical OfficerVolker Knappertz

Company Highlights

Price Open$154.10
Previous Close$152.92
52 Week Range$90.14 - 196.00
Market Capitalization$4.8 B
Shares Outstanding30.9 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement11/26/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$8.12
Beta vs. S&P 500N/A
Revenue$15.5 M
Net Profit Margin-453.88%
Return on Equity-41.75%

Analyst Ratings as of 08/09/2019

Buy
13
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset